Abacavir use and risk of recurrent myocardial infarction
Caroline Sabin(Primary Health Care), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Andrew Phillips(Wake Forest University), Wafaa El‐Sadr(Columbia University Irving Medical Center), Ole Kirk(University of Copenhagen), Fabrice Bonnet(Centre Hospitalier Universitaire de Bordeaux), Christian Pradier(Université Côte d'Azur), Amanda Mocroft(University of Copenhagen), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Matthew Law(UNSW Sydney), Camilla I. Hatleberg, Peter Reiss(Amsterdam Institute for Global Health and Development), Stéphane De Wit(Centre Hospitalier Universitaire de Saint-Pierre), Lene Ryom(University of Copenhagen)
Cited by 20
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k